NDC 11695-7009-2 - Gentamicin Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11695-7009
- Requested NDC
- 11695-7009-2
- Package NDCs from labels
- 11695-7009-1, 11695-7009-2, 11695-7009-3
- Manufacturer
- Covetrus North America
- Effective date
- 2025-06-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gentamicin Sulfate - Covetrus North America | Covetrus North America | 2025-06-23 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11695-7009-1 | Gentamicin Sulfate | 60 mL in 1 BOTTLE, SPRAY | SPRAY | 60 | 2 | |
| 11695-7009-2 | Gentamicin Sulfate | 120 mL in 1 BOTTLE, SPRAY | SPRAY | 120 | 2 | |
| 11695-7009-3 | Gentamicin Sulfate | 240 mL in 1 BOTTLE, SPRAY | SPRAY | 240 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11695-7009 | GENTAMICIN SULFATE SPRAY [COVETRUS NORTH AMERICA] | 1 | 3 package rows | 20241030_e732e591-fe4e-4fef-a9ea-ba3a0495995e.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentamicin Sulfate | GENTAMICIN SULFATE | Hospira, Inc. | 977180b3-a222-4282-d485-4a3217674305 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cardinal Health 107, LLC | 5113bfad-42ca-4bb8-9343-0b08c6cd03f0 | 2026-05-08 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Preferred Pharmaceuticals Inc. | 5ac8ea7a-ee89-49f5-8d30-6dbb56503d94 | 2026-05-05 | Warnings, Adverse reactions | 8X7386QRLV |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Sun Pharmaceutical Industries, Inc. | 7c96b978-25ff-44c2-bc9c-30ff5e34cffb | 2026-03-23 | Warnings, Adverse reactions | 9IFA5XM7R2 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Preferred Pharmaceuticals Inc. | 50d4763d-5a84-4c45-be06-040c4a527470 | 2026-03-19 | Adverse reactions | 9IFA5XM7R2 |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | Preferred Pharmaceuticals, Inc. | bfa4b6f5-3b66-430a-af41-60e3f12982bc | 2026-03-19 | Adverse reactions | 9IFA5XM7R2 |
| Gentamicin Sulfate Opth Solution | GENTAMICIN SULFATE OPTH SOLUTION | Direct_Rx | e1a5bc32-f9a0-6b33-e053-2995a90ab9ac | 2026-03-17 | Warnings, Adverse reactions | 8X7386QRLV |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | A-S Medication Solutions | 7281d272-5342-4738-b35c-42570459e9d4 | 2026-02-04 | Adverse reactions | 9IFA5XM7R2 |
| Gentamicin | GENTAMICIN | Eugia US LLC | 60ca1487-392d-4721-aa45-3de38722896c | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Betamethasone Valerate | BETAMETHASONE VALERATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 0b386ccc-a2d4-4d18-a2d7-e46ff894c674 | 2026-01-28 | Adverse reactions | 9IFA5XM7R2 |
| Gentamicin | GENTAMICIN | Eugia US LLC | f8c608b3-50b8-4d5d-9e8a-e92c0d2e3cdc | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Henry Schein, Inc | 84f6eb1c-a287-489a-8c3e-aa5954cf1992 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Henry Schein, Inc. | 913a36c3-50d6-429a-a8dd-a03126d2ca08 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | Sun Pharmaceutical Industries, Inc. | 3c85be0f-2731-44f1-a18e-d3852d54846f | 2025-10-02 | Adverse reactions | 9IFA5XM7R2 |
| Betamethasone valerate | BETAMETHASONE VALERATE | Alembic Pharmaceuticals Limited | 75d70e76-023c-4a00-954d-79a697bed80f | 2025-09-25 | Adverse reactions | 9IFA5XM7R2 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 3532bb39-a1a6-9d67-e063-6294a90abc0c | 2025-05-15 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 5193ed8d-44c9-46fe-924d-93aaea922cfd | 2025-05-01 | Warnings, Adverse reactions | 8X7386QRLV |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Preferred Pharmaceuticals Inc. | 985d1f62-4bff-4bf1-b7c7-96cb456ef83d | 2025-02-07 | Adverse reactions | 9IFA5XM7R2 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 0bef2a01-69d0-cf50-e063-6294a90a4c52 | 2025-02-03 | Warnings, Adverse reactions | 8X7386QRLV |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | A-S Medication Solutions | 02db1402-701c-483c-bfd6-8b7a543ae8ef | 2024-11-11 | Adverse reactions | 9IFA5XM7R2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.